Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study of the QOL Evaluation of Trelagliptin in Patients With Type 2 Diabetes Mellitus

NCT03014479 is registered in ClinicalTrials.gov with Takeda as lead sponsor.

NCT NCT03014479
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03014479 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study of the QOL Evaluation of Trelagliptin in Patients With Type 2 Diabetes Mellitus
Lead sponsor
Takeda
Phase
Phase 4
Overall status
Completed
Start date
February 18, 2017
Completion date
October 21, 2017
Enrollment
219 (actual)
Sites
27

Conditions

As the registry lists them; a condition with its own page is linked.

type 2 diabetes